Search

OBJECTIVE: To investigate whether retinoid X receptor agonists act as insulin sensitizers and compare their effects with that of thiazolidinedione BRL 49653 in obese Zucker rats. DESIGN: In two independent studies, obese Zucker rats were dosed orally once daily for 14 days with one of the following treatments: LG 100268 (20 mg/kg), LG 100324 (20 mg/kg), BRL 49653 (3 mg/kg) or vehicle. MEASUREMENTS: Daily food intake and body weight gain, blood glucose, plasma and pancreatic insulin, whole body glucose disposal (by euglycaemic–hyperinsulinaemic clamp) and tissue glucose utilization. RESULTS: The retinoid X receptor agonists (rexinoids) LG 100268 and LG 100324 caused a reduction in the food intake of obese Zucker rats relative to controls and to rats receiving BRL 49653. The two rexinoids also produced a marked decrease in the body weight gain, whereas the growth rate of rats treated with BRL 49653 tended to increase. Both rexinoids and BRL 49653 reduced the plasma insulin concentration of fed rats. LG 100268 and LG 100324 also significantly lowered blood glucose concentrations after 1 week of treatment. The 5 h fasted plasma insulin concentration was significantly lower in the rexinoid-treated groups and the terminal insulin level (at the end of the clamp) tended to be lower in all treated groups compared with animals given the dosing vehicle. However, pancreatic insulin content was not affected by any of the treatments. Under euglycaemic–hyperinsulinaemic clamp conditions, there were no significant differences in the rate of hepatic glucose output and whole body glucose disposal, except that, in experiment 1, BRL 49653 caused significant increase in the glucose infusion rate and muscle glucose utilization. In experiment 2, a similar glucose infusion rate to the controls was achieved in all treatment groups but the steady-state insulin concentration in the treated animals was only about 50% of that in the control animals, despite the fact that all... [ABSTRACT FROM AUTHOR]

The neurointermediate pituitary peptide beta-cell tropin (BCT) has potent insulin-releasing and lipogenic properties and is elevated in obesity and type-2 diabetes. The effects of BCT and glucose on the release of insulin and amylin from the perfused pancreas of obese 'fatty' (fa/fa) rats and lean (Fa/?) controls were measured. Pancreata were perfused, sequentially, with buffer containing: 5.6 mmol glucose/l (basal); basal glucose +/- 0.5 nmol BCT/l; 16.7 mmol glucose/l (high). Insulin and amylin release during basal glucose treatment was eight to nine times greater from pancreata from fatty than from lean rats. BCT induced a fivefold greater monophasic insulin and amylin release from fatty compared with lean pancreata. When not preceded by BCT there was a twofold greater high glucose-induced amylin release from fatty pancreata but no difference in insulin secretion. When preceded by BCT stimulation, high glucose induced twofold greater insulin and fourfold larger amylin release from fatty compared with lean pancreata. Molar secretion ratios of insulin:amylin varied between 30:1 and 50:1. In view of the elevated levels of BCT found in the fatty rat and in the light of the above findings, it is concluded that the peptide may have a role in the development of hyperinsulinaemia, hyperamylinaemia and insulin resistance in this animal model of obesity and diabetes.

Inkbraille, a reduced size ink-image version of the familiar braille code, was conceived in an attempt to sidestep the major disadvantages of embossed braille, while retaining the unsurpassed reading rates achieved by the blind using that code. Inkbraille would ultimately be translated by a specially designed hand-held electronic device with appropriate tactile output. Such a device is not yet available, so in this study we test the readability of Inkbraille when read by means of a commercially available electronic reading aid, the Optacon, which presents its output tactually on a field of vibrating pins which are sensed with a finger. Three modes of tactual reading were compared: conventional embossed braille, and the Opticon's vibrating-pinfield presentation of typed letters and its presentation of Inkbraille. All subjects were able to read Inkbraille upon initial exposure. Subjects who were tested in multiple sessions exhibited significant increases in Inkbraille reading rates after only limited exposure. Since Inkbraille and letterprint reading rates were the same in this study, the results led the authors to conclude that a rate limitation may have been imposed by the device (the Optacon) that was used to translate both the Inkbraille and the letterprint.

Tactual reading usually requires the coordinated use of the forearm/hand motor and tactile sensory systems. Therefore, in a series of studies of tactual reading behavior, we chose to record the text-scanning patterns of adult blind readers in an attempt to gain further insight into the nature of this process. Reading behavior for four modes of tactual reading was recorded (embossed braille one-hand, embossed braille two-hands, Optacon/letterprint, and Optacon/Inkbraille) by detecting and recording the instantaneous position of light-emitting diodes unobtrusively attached to the finger(s) or the Optacon camera. In addition to the comparative evaluation of the four sets of reading patterns, the salient features of the Optacon/letterprint patterns were quantitatively analyzed in an attempt to characterize this particular mode of reading. The text-scanning patterns of Optacon readers have not been previously reported. In general the text-scanning behavior for all modes of tactual reading seems to be similar; the only remarkable difference appears to be in the reading rates. Regarding Optacon/letterprint performance, reading rate was found to be significantly and negatively correlated with line-changing time and the number of regressions. No significant correlation was evident between rate and regression magnitude.